AZD7762 10mg 10mg | Purity Not Available
Adooq Bioscience
AZD7762 is a potent ATP-competitive checkpoint kinase inhibitor that drives checkpoint abrogation and potentiates DNA-targeted therapies.
More Information Supplier PageAZD7762 is a potent ATP-competitive checkpoint kinase inhibitor that drives checkpoint abrogation and potentiates DNA-targeted therapies.
More Information Supplier PageAZD6482 is a PI3Kbeta inhibitor (IC50=0.021M) used in antithrombotic therapy.
More Information Supplier PageAZD6482 is a PI3Kbeta inhibitor (IC50=0.021M) used in antithrombotic therapy.
More Information Supplier PageAZD6482 is a PI3Kbeta inhibitor (IC50=0.021M) used in antithrombotic therapy.
More Information Supplier PageAZD6482 is a PI3Kbeta inhibitor (IC50=0.021M) used in antithrombotic therapy.
More Information Supplier PageAZD6482 is a PI3Kbeta inhibitor (IC50=0.021M) used in antithrombotic therapy.
More Information Supplier PageAZD7762 is a potent ATP-competitive checkpoint kinase inhibitor that drives checkpoint abrogation and potentiates DNA-targeted therapies.
More Information Supplier PageAZD8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM.
More Information Supplier PageAZD8330 is a MEK inhibitor that specifically inhibits mitogen-activated protein kinase kinase 1 (MEK or MAP/ERK kinase1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation.
More Information Supplier PageAZD8330 is a MEK inhibitor that specifically inhibits mitogen-activated protein kinase kinase 1 (MEK or MAP/ERK kinase1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation.
More Information Supplier Page